financetom
Business
financetom
/
Business
/
New England states move forward with three giant offshore wind farms
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
New England states move forward with three giant offshore wind farms
Sep 6, 2024 1:37 PM

NEW YORK, Sept 6 (Reuters) - Massachusetts and Rhode

Island are moving ahead with three offshore wind projects

totaling 2.9 gigawatts (GW), or enough electricity to power

about 1.6 million homes, government officials announced on

Friday.

The project selections, following a joint solicitation in

March for wind farms to be built off of New England's shores,

move Massachusetts and Rhode Island closer to state renewable

energy goals aimed at combating the effects of climate change.

"We are taking an important step towards energy

independence, cleaner air and transforming our economy,"

Governor Maura Healey said in a statement.

The U.S. offshore wind industry has stabilized in the second

half of 2024, after a disastrous pervious year that saw

developers cancel multiple project contracts and take $9.1

billion in write-offs and impairments on abandoned projects.

New England's newly selected offshore projects include

SouthCoast Wind, New England Wind 1 and Vineyard Wind 2.

Avangrid ( AGR ) is behind New England Wind 1, Southcoast is backed by a

joint venture between EDP Energias de Portugal and

Engie and Vineyard Wind 2 is being developed by

Vineyard Offshore, which is held by funds managed by Copenhagen

Infrastructure Partners.

The projects are expected to begin delivering power in

around the end of the decade.

Federal and state climate pledges have largely centered

around decarbonizing electrical grids by replacing fossil-fired

power with renewable wind and solar. Massachusetts aims to slash

its power sector's carbon emissions by 50% by 2030 and 100% by

2050. The much smaller Rhode Island has set a goal to use all

renewables by 2033.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Nvidia Insider Sold Shares Worth $4,355,785, According to a Recent SEC Filing
Nvidia Insider Sold Shares Worth $4,355,785, According to a Recent SEC Filing
May 31, 2024
04:00 AM EDT, 05/31/2024 (MT Newswires) -- Michael G McCaffery, Director, on May 28, 2024, sold 3,879 shares in Nvidia ( NVDA ) for $4,355,785. Following the Form 4 filing with the SEC, McCaffery has control over a total of 9,687 shares of the company, with 9,687 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1045810/000104581024000129/xslF345X03/wk-form4_1717100932.xml Price: 1,093.50, Change: -11.50, Percent Change: -1.04...
Kontoor Brands Insider Sold Shares Worth $7,899,959, According to a Recent SEC Filing
Kontoor Brands Insider Sold Shares Worth $7,899,959, According to a Recent SEC Filing
May 31, 2024
04:00 AM EDT, 05/31/2024 (MT Newswires) -- Scott H Baxter, Director, Chair, President and Chief Executive Officer, on May 28, 2024, sold 110,092 shares in Kontoor Brands ( KTB ) for $7,899,959. Following the Form 4 filing with the SEC, Baxter has control over a total of 477,257 shares of the company, with 318,188 shares held directly and 159,069 controlled...
--Meta Platforms Maintains Quarterly Dividend at $0.50 a Share, Payable June 26 to Shareholders as of June 14
--Meta Platforms Maintains Quarterly Dividend at $0.50 a Share, Payable June 26 to Shareholders as of June 14
May 31, 2024
04:04 AM EDT, 05/31/2024 (MT Newswires) -- Price: 465.88, Change: -1.17, Percent Change: -0.25 ...
Galapagos, Adaptimmune Therapeutics Team Up to Evaluate Head and Neck Cancer Drug
Galapagos, Adaptimmune Therapeutics Team Up to Evaluate Head and Neck Cancer Drug
May 31, 2024
04:01 AM EDT, 05/31/2024 (MT Newswires) -- Galapagos (GLPG) and Adaptimmune Therapeutics ( ADAP ) have entered into a clinical collaboration deal to evaluate the safety and efficacy of Adaptimmune's uza-cel in head and neck cancer using Galapagos' decentralized cell manufacturing platform, the companies said late Thursday. Under the deal, Adaptimmune will receive $100 million in initial payments, consisting of...
Copyright 2023-2026 - www.financetom.com All Rights Reserved